AMCP Annual Meeting
We’re looking forward to engaging with industry leaders in person at the AMCP on March 21–24, 2023, in San Antonio, TX.
Inflation Reduction Act (IRA) Implementation: Inflation-based rebates, Medicare price negotiation, Part D benefit design, and other IRA policies will have a profound impact on healthcare stakeholders. Avalere can help evaluate these policies’ effects and develop strategies for product development and investment decisions, manufacturer contracting strategies, plan formulary and benefit design, and ensuring patient access to medications.
Rethinking Evidence and Value Communication: The IRA is amplifying focus on the value of medication, increasing the need for all healthcare stakeholders to consider innovative approaches to evidence generation and the measurement of value. Our experts can share perspectives from the lens of policy, payer, and life sciences to provide insights on how anticipated market changes will drive behavioral changes across key stakeholders as they make decisions to maintain their business.
Part D Redesign Strategy and Modeling: Part D benefit redesign will add pressure to plans and manufacturers, while increasing affordability for beneficiaries. Manufacturers can expect Part D volume and revenue changes and should prepare for new plan approaches to formulary and benefit design. Avalere can be a thought partner to manufacturers developing their strategy for engaging Part D plans for 2025 using qualitative and quantitative approaches.
The Avalere experts below will attend AMCP 2023.
Read Our Take on Top Trends
Implementation of the OOP smoothing program will require additional clarity from the Centers for Med...
Patient-Centered Research & Outcomes
Gain insights needed to drive organizational goals while improving patient experiences and outcomes.
Market Access and Commercialization
We help life sciences companies successfully initiate and sustain product commercialization.
Federal and State Healthcare Policy Consulting
We provide clients with multistakeholder perspectives on federal and state healthcare policy to help them navigate the complex legislative and regulatory environment.